PROFUND ADVISORS LLC

Position in HLN — Haleon plc

CIK 1129919 BETHESDA, MD

Position in HLN

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$506,395

-$84,665 QoQ

Shares Held

50,589

-13.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PROFUND ADVISORS LLC holds $17,208,250 across 29 Drug Manufacturers - Specialty & Generic names. HLN ranks #7 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	4,687	$2,779,297
2	ALKS	Alkermes plc.	77,769	$2,749,911
3	NBIX	Neurocrine Biosciences Inc	17,687	$2,330,085
4	BCRX	Biocryst Pharmaceuticals Inc	158,462	$1,508,558
5	ZTS	Zoetis Inc.	6,653	$786,451
6	ELAN	Elanco Animal Health Inc	22,305	$533,758
7	HLN	Haleon plc This page	50,589	$506,395
8	VTRS	Viatris Inc	29,453	$397,910

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$506,395	50,589	-13.5%	Shares	Sole	2026-04-27
2025-12-31	$591,060	58,463	+27.8%	Shares	Sole	2026-02-06
2025-09-30	$410,386	45,751	-19.7%	Shares	Sole	2025-11-06
2025-06-30	$590,861	56,978	+3.6%	Shares	Sole	2025-08-07
2025-03-31	$566,042	55,009	+53.6%	Shares	Sole	2025-05-08
2024-12-31	$341,665	35,814	-23.5%	Shares	Sole	2025-02-14
2024-09-30	$495,429	46,827	-13.1%	Shares	Sole	2024-11-14
2024-06-30	$445,123	53,889	+3.0%	Shares	Sole	2024-08-13
2024-03-31	$444,247	52,326	-12.3%	Shares	Sole	2024-05-08
2023-12-31	$490,968	59,656	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.